Literature DB >> 34118203

Oncogene-regulated release of extracellular vesicles.

Seda Kilinc1, Rebekka Paisner2, Roman Camarda3, Suprit Gupta4, Olga Momcilovic2, Rebecca A Kohnz5, Baris Avsaroglu2, Noelle D L'Etoile2, Rushika M Perera6, Daniel K Nomura5, Andrei Goga7.   

Abstract

Oncogenes can alter metabolism by changing the balance between anabolic and catabolic processes. However, how oncogenes regulate tumor cell biomass remains poorly understood. Using isogenic MCF10A cells transformed with nine different oncogenes, we show that specific oncogenes reduce the biomass of cancer cells by promoting extracellular vesicle (EV) release. While MYC and AURKB elicited the highest number of EVs, each oncogene selectively altered the protein composition of released EVs. Likewise, oncogenes alter secreted miRNAs. MYC-overexpressing cells require ceramide, whereas AURKB requires ESCRT to release high levels of EVs. We identify an inverse relationship between MYC upregulation and activation of the RAS/MEK/ERK signaling pathway for regulating EV release in some tumor cells. Finally, lysosome genes and activity are downregulated in the context of MYC and AURKB, suggesting that cellular contents, instead of being degraded, were released via EVs. Thus, oncogene-mediated biomass regulation via differential EV release is a new metabolic phenotype.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AURKB; ESCRT; EVs; HRAS; MYC; ceramide; extracellular vesicles; lysosome; miRNAs; oncogenes

Mesh:

Substances:

Year:  2021        PMID: 34118203      PMCID: PMC8292920          DOI: 10.1016/j.devcel.2021.05.014

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  87 in total

Review 1.  Assigning significance to peptides identified by tandem mass spectrometry using decoy databases.

Authors:  Lukas Käll; John D Storey; Michael J MacCoss; William Stafford Noble
Journal:  J Proteome Res       Date:  2007-12-08       Impact factor: 4.466

2.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.

Authors:  Laura Santangelo; Giorgio Giurato; Carla Cicchini; Claudia Montaldo; Carmine Mancone; Roberta Tarallo; Cecilia Battistelli; Tonino Alonzi; Alessandro Weisz; Marco Tripodi
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

Review 3.  Extracellular vesicles: biology and emerging therapeutic opportunities.

Authors:  Samir EL Andaloussi; Imre Mäger; Xandra O Breakefield; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2013-04-15       Impact factor: 84.694

Review 4.  Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.

Authors:  Dongsic Choi; Tae Hoon Lee; Cristiana Spinelli; Shilpa Chennakrishnaiah; Esterina D'Asti; Janusz Rak
Journal:  Semin Cell Dev Biol       Date:  2017-01-08       Impact factor: 7.727

5.  Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity.

Authors:  Arash Latifkar; Lu Ling; Amrit Hingorani; Eric Johansen; Amdiel Clement; Xiaoyu Zhang; John Hartman; Claudia Fischbach; Hening Lin; Richard A Cerione; Marc A Antonyak
Journal:  Dev Cell       Date:  2019-04-11       Impact factor: 12.270

6.  Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.

Authors:  Dong Wang; Chengxiang Qiu; Haijun Zhang; Juan Wang; Qinghua Cui; Yuxin Yin
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 7.  Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Authors:  Kristopher R Bosse; John M Maris
Journal:  Cancer       Date:  2015-11-05       Impact factor: 6.860

8.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

Review 9.  Membrane curvature at a glance.

Authors:  Harvey T McMahon; Emmanuel Boucrot
Journal:  J Cell Sci       Date:  2015-03-15       Impact factor: 5.285

10.  Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.

Authors:  Roman Camarda; Alicia Y Zhou; Rebecca A Kohnz; Sanjeev Balakrishnan; Celine Mahieu; Brittany Anderton; Henok Eyob; Shingo Kajimura; Aaron Tward; Gregor Krings; Daniel K Nomura; Andrei Goga
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440

View more
  7 in total

1.  Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.

Authors:  Joyce V Lee; Filomena Housley; Christina Yau; Rachel Nakagawa; Juliane Winkler; Johanna M Anttila; Pauliina M Munne; Mariel Savelius; Kathleen E Houlahan; Daniel Van de Mark; Golzar Hemmati; Grace A Hernandez; Yibing Zhang; Susan Samson; Carole Baas; Laura J Esserman; Laura J van 't Veer; Hope S Rugo; Christina Curtis; Juha Klefström; Mehrdad Matloubian; Andrei Goga
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

2.  Zooming in on the cell biology of disease.

Authors:  Rushika M Perera
Journal:  Mol Biol Cell       Date:  2021-12-01       Impact factor: 4.138

Review 3.  Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection.

Authors:  Mark S Gibson; Cláudia Noronha-Estima; Margarida Gama-Carvalho
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

Review 4.  Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis.

Authors:  Kangkang Yang; Quanbo Zhou; Bingbing Qiao; Bo Shao; Shengyun Hu; Guixian Wang; Weitang Yuan; Zhenqiang Sun
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-19       Impact factor: 8.886

Review 5.  Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks.

Authors:  Sarah Beck; Bernhard Hochreiter; Johannes A Schmid
Journal:  Front Cell Dev Biol       Date:  2022-03-17

6.  Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells.

Authors:  Lisa L Kirkemo; Susanna K Elledge; Jiuling Yang; James R Byrnes; Jeff E Glasgow; Robert Blelloch; James A Wells
Journal:  Elife       Date:  2022-03-08       Impact factor: 8.713

7.  MEK/ERK-mediated oncogenic signals promote secretion of extracellular vesicles by controlling lysosome function.

Authors:  Tomoya Hikita; Ryo Uehara; Reina E Itoh; Fumie Mitani; Mamiko Miyata; Takuya Yoshida; Rui Yamaguchi; Chitose Oneyama
Journal:  Cancer Sci       Date:  2022-02-13       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.